Nautilus Biotechnology, Inc. (NAUT) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Seattle, WA, 미국. 현재 CEO는 Sujal Patel.
NAUT 을(를) 보유 IPO 날짜 2020-08-07, 134 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $387.29M.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
